Skip to main content
. 2018 Jun 21;8:9471. doi: 10.1038/s41598-018-27908-x

Figure 1.

Figure 1

Flowchart of patient selection, exclusion and multi drug resistant (MDR) rates. The study period extended from July 1st 2009 to December 31st 2014. Only patients admitted at least once and from whom at least one microbiological specimen was obtained were included in the study. Patients were classified into three groups and in each, the rate of MDR bacteria was calculated twice, once excluding and once including carbapenem-resistant Pseudomonas aeruginosa (CR-PA) and extended-spectrum-beta-lactamase producing Enterobacteriaceae (ESBL-PE) (see text).